IHC characteristics of stem cell markers in PDAC with different degrees of differentiation

Introduction. Cancer stem cells (CSCs) play a key role in the development, progression and metastasis of cancer. Cell surface markers, in particular CD44 and EpCAM, are used to identify CSCs. Marker expression patterns depend on the stage of progression and differentiation. Materials and methods. Hi...

Full description

Saved in:
Bibliographic Details
Main Authors: V. Kabachenko (Author), M. Shishkin (Author)
Format: Book
Published: Kazimierz Wielki University, 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_81f28d1baffe44c58a5abec12923043f
042 |a dc 
100 1 0 |a V. Kabachenko  |e author 
700 1 0 |a M. Shishkin  |e author 
245 0 0 |a IHC characteristics of stem cell markers in PDAC with different degrees of differentiation 
260 |b Kazimierz Wielki University,   |c 2022-06-01T00:00:00Z. 
500 |a 10.12775/JEHS.2022.12.06.023 
500 |a 2391-8306 
520 |a Introduction. Cancer stem cells (CSCs) play a key role in the development, progression and metastasis of cancer. Cell surface markers, in particular CD44 and EpCAM, are used to identify CSCs. Marker expression patterns depend on the stage of progression and differentiation. Materials and methods. Histopathological and IHC studies of 49 cases of the pancreas ductal adenocarcinoma (PDAC) of G2, G3 degrees of differentiation. Results of IHC reactions with antibodies against CD44 and EpCAM were estimated by photo digital morphometry and were expressed in immunostained cells relative area (%). Results. Adenocarinoma of the pancreas is characterized by a moderate level of expression of cell surface markers CSC - CD44 and EpCAM. The expression level of CD44 in the І gr. - Me = 34.11% (Q1 = 31.03; Q3 = 38.39), in the II gr. - Me = 43.17% (Q1 = 39.83; Q3 = 47.04), significantly higher than in the I gr. (Kruskal-Wallis test p<0.05). The expression level of EpCAM in the I gr. - Ме=26,10% (Q1=20,42; Q3=31,89), in the II gr. - Ме=31,07% (Q1=27,03; Q3=34,00) (p>0,05). In both groups, the relative area of EpCAM was significantly lower than CD44 (Kruskal-Wallis test p<0.05). Correlation analysis (Pearson's ratio) showed a weak negative relationship between markers at G2 (r = -0.17, p>0.05), at G3 - a weak positive (r = + 0.06, p>0.05). 
546 |a EN 
546 |a ES 
546 |a PL 
546 |a RU 
546 |a UK 
690 |a Pancreas 
690 |a Ductal adenocarcinoma 
690 |a Cancer stem cells 
690 |a EpCAM 
690 |a CD44 
690 |a Education 
690 |a L 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Medicine 
690 |a R 
655 7 |a article  |2 local 
786 0 |n Journal of Education, Health and Sport, Vol 12, Iss 6 (2022) 
787 0 |n https://apcz.umk.pl/JEHS/article/view/38817 
787 0 |n https://doaj.org/toc/2391-8306 
856 4 1 |u https://doaj.org/article/81f28d1baffe44c58a5abec12923043f  |z Connect to this object online.